Related Experiment Video

Updated: Jun 8, 2026

Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets
08:12

Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets

Published on: September 6, 2019

Pediatric aspects of HIV1-infection--an overview

B Buchholz1, S Hien, S Weichert

  • 1Department of Paediatrics, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany. bernd.buchholz@umm.de

Minerva Pediatrica
|October 14, 2010
PubMed

Insights

Preventing mother-to-child HIV transmission involves prenatal testing and prophylactic interventions. Highly active antiretroviral therapy (HAART) has transformed pediatric HIV into a manageable chronic condition, though lifelong treatment presents challenges.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Mother-to-child transmission (MTCT) of Human Immunodeficiency Virus type 1 (HIV-1) is the primary cause of pediatric HIV-1 infection.
  • In developed countries, MTCT rates have decreased from 40% to 1-2% due to combined antiretroviral therapy (ART) in pregnant women, neonatal prophylaxis, and avoidance of breastfeeding.
  • Current challenges include lack of prenatal HIV testing and insufficient knowledge regarding prophylactic interventions for HIV-1-positive pregnant women and their newborns.

Purpose of the Study:

  • To review the current strategies and challenges in preventing and managing pediatric HIV-1 infection.
  • To highlight the impact of highly active antiretroviral therapy (HAART) on pediatric HIV-1 outcomes.
  • To discuss the difficulties in diagnosing HIV-1 in infants and the complexities of long-term treatment in children.

Main Methods:

  • Literature review of HIV-1 prevention and treatment strategies in pediatric populations.
  • Analysis of the evolution of pediatric HIV-1 management since the advent of HAART.
  • Discussion of diagnostic challenges and therapeutic considerations for HIV-1-infected children.

Main Results:

  • Effective MTCT prevention strategies have significantly reduced pediatric HIV-1 incidence.
  • HAART has transitioned pediatric HIV-1 from a fatal to a chronic illness with improved quality of life.
  • Diagnosis in infants is complicated by maternal antibodies, and pediatric HIV-1 treatment faces hurdles due to drug formulation, pharmacokinetic data, and adherence issues.

Conclusions:

  • Continued emphasis on prenatal HIV testing and knowledge dissemination on prophylactic measures is crucial.
  • Lifelong HAART is necessary for pediatric HIV-1 management, posing challenges in adherence and long-term adverse effect monitoring.
  • Further research and development are needed for optimized pediatric HIV-1 treatment regimens and formulations.

More Related Videos

Peptide-based Identification of Functional Motifs and their Binding Partners14:28

Peptide-based Identification of Functional Motifs and their Binding Partners

Published on: June 30, 2013

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...